Faster access than browser!Similarities between Endometrial cancer and Tamoxifen
Endometrial cancer and Tamoxifen have 13 things in common (in Unionpedia): American Cancer Society, Anastrozole, Angiogenesis, Aromatase inhibitor, Breast cancer, Cancer, Cell cycle, Endometrium, Estrogen receptor, HER2/neu, Menopause, Raloxifene, Uterine cancer.
American Cancer Society
The American Cancer Society (ACS) is a nationwide voluntary health organization dedicated to eliminating cancer.
American Cancer Society and Endometrial cancer · American Cancer Society and Tamoxifen ·
Anastrozole
Anastrozole, sold under the brand name Arimidex among others, is a medication used in addition to other treatments for breast cancer.
Anastrozole and Endometrial cancer · Anastrozole and Tamoxifen ·
Angiogenesis
Angiogenesis is the physiological process through which new blood vessels form from pre-existing vessels.
Angiogenesis and Endometrial cancer · Angiogenesis and Tamoxifen ·
Aromatase inhibitor
Aromatase inhibitors (AIs) are a class of drugs used in the treatment of breast cancer in postmenopausal women and gynecomastia in men.
Aromatase inhibitor and Endometrial cancer · Aromatase inhibitor and Tamoxifen ·
Breast cancer
Breast cancer is cancer that develops from breast tissue.
Breast cancer and Endometrial cancer · Breast cancer and Tamoxifen ·
Cancer
Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body.
Cancer and Endometrial cancer · Cancer and Tamoxifen ·
Cell cycle
The cell cycle or cell-division cycle is the series of events that take place in a cell leading to its division and duplication of its DNA (DNA replication) to produce two daughter cells.
Cell cycle and Endometrial cancer · Cell cycle and Tamoxifen ·
Endometrium
The endometrium is the inner epithelial layer, along with its mucous membrane, of the mammalian uterus.
Endometrial cancer and Endometrium · Endometrium and Tamoxifen ·
Estrogen receptor
Estrogen receptors (ERs) are a group of proteins found inside cells.
Endometrial cancer and Estrogen receptor · Estrogen receptor and Tamoxifen ·
HER2/neu
Receptor tyrosine-protein kinase erbB-2, also known as CD340 (cluster of differentiation 340), proto-oncogene Neu, Erbb2 (rodent), or ERBB2 (human), is a protein that in humans is encoded by the ERBB2 gene.
Endometrial cancer and HER2/neu · HER2/neu and Tamoxifen ·
Menopause
Menopause, also known as the climacteric, is the time in most women's lives when menstrual periods stop permanently, and they are no longer able to bear children.
Endometrial cancer and Menopause · Menopause and Tamoxifen ·
Raloxifene
Raloxifene, developed by Eli Lilly in 1997 and sold under the brand name Evista among others, is a medication which is used in the prevention and treatment of osteoporosis in postmenopausal women and to reduce the risk of breast cancer in postmenopausal women with osteoporosis or at high risk for breast cancer.
Endometrial cancer and Raloxifene · Raloxifene and Tamoxifen ·
Uterine cancer
Uterine cancer, also known as womb cancer, is any type of cancer that emerges from the tissue of the uterus.
Endometrial cancer and Uterine cancer · Tamoxifen and Uterine cancer ·
The list above answers the following questions
- What Endometrial cancer and Tamoxifen have in common
- What are the similarities between Endometrial cancer and Tamoxifen
Endometrial cancer and Tamoxifen Comparison
Endometrial cancer has 236 relations, while Tamoxifen has 111. As they have in common 13, the Jaccard index is 3.75% = 13 / (236 + 111).
References
This article shows the relationship between Endometrial cancer and Tamoxifen. To access each article from which the information was extracted, please visit:
